Enliven Therapeutics, Inc. (ELVN)

NASDAQ: ELVN · IEX Real-Time Price · USD
17.59
-1.04 (-5.58%)
At close: Mar 28, 2024, 4:00 PM
17.10
-0.49 (-2.80%)
After-hours: Mar 28, 2024, 5:25 PM EDT

Total Valuation

ELVN has a market cap or net worth of $727.30 million. The enterprise value is $474.10 million.

Market Cap 727.30M
Enterprise Value 474.10M

Important Dates

The last earnings date was Thursday, March 14, 2024, after market close.

Earnings Date Mar 14, 2024
Ex-Dividend Date n/a

Share Statistics

ELVN has 41.35 million shares outstanding. The number of shares has increased by 1,037.74% in one year.

Shares Outstanding 41.35M
Shares Change (YoY) +1,037.74%
Shares Change (QoQ) +0.39%
Owned by Insiders (%) 6.96%
Owned by Institutions (%) 80.99%
Float 12.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.96
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.28, with zero debt.

Current Ratio 10.28
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -26.60% and return on invested capital (ROIC) is -33.97%.

Return on Equity (ROE) -26.60%
Return on Assets (ROA) -25.20%
Return on Capital (ROIC) -33.97%
Revenue Per Employee n/a
Profits Per Employee -$1.56M
Employee Count 46
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.12% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -25.12%
50-Day Moving Average 15.85
200-Day Moving Average 15.17
Relative Strength Index (RSI) 56.02
Average Volume (30 Days) 138,126

Short Selling Information

The latest short interest is 4.33 million, so 10.47% of the outstanding shares have been sold short.

Short Interest 4.33M
Short Previous Month 4.33M
Short % of Shares Out 10.47%
Short % of Float 34.61%
Short Ratio (days to cover) 41.97

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -83.53M
Pretax Income -71.58M
Net Income -71.58M
EBITDA -70.98M
EBIT -71.58M
Earnings Per Share (EPS) -$2.01
Full Income Statement

Balance Sheet

The company has $253.20 million in cash and no debt, giving a net cash position of $253.20 million or $6.12 per share.

Cash & Cash Equivalents 253.20M
Total Debt n/a
Net Cash 253.20M
Net Cash Per Share $6.12
Equity / Book Value 245.91M
Book Value Per Share 5.95
Working Capital 240.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.27 million and capital expenditures -$149,000, giving a free cash flow of -$61.42 million.

Operating Cash Flow -61.27M
Capital Expenditures -149,000
Free Cash Flow -61.42M
FCF Per Share -$1.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ELVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,037.74%
Shareholder Yield -1,037.74%
Earnings Yield -9.84%
FCF Yield -8.44%

Analyst Forecast

The average price target for ELVN is $27.00, which is 53.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $27.00
Price Target Difference 53.50%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on February 24, 2023. It was a reverse split with a ratio of 1:4.

Last Split Date Feb 24, 2023
Split Type Reverse
Split Ratio 1:4

Scores

Altman Z-Score n/a
Piotroski F-Score 2